Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Zoetis Inc.
  6. Summary
    ZTS   US98978V1035

ZOETIS INC.

(ZTS)
  Report
Delayed Quote. Delayed Nyse - 12/03 04:10:00 pm
223.33 USD   +0.06%
12/02Zoetis Named One of Newsweek's Most Responsible Companies for 2022
BU
11/29INSIDER SELL : Zoetis
MT
11/18ZOETIS : Top Company for Executive Women
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
223.55(c) 222.04(c) 219.66(c) 223.19(c) 223.33(c) Last
1 391 634 3 828 401 2 042 751 1 705 641 1 478 217 Volume
+1.93% -0.68% -1.07% +1.61% +0.06% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 7 745 M - -
Net income 2021 2 020 M - -
Net Debt 2021 3 092 M - -
P/E ratio 2021 52,5x
Yield 2021 0,44%
Sales 2022 8 407 M - -
Net income 2022 2 275 M - -
Net Debt 2022 1 821 M - -
P/E ratio 2022 46,4x
Yield 2022 0,53%
Capitalization 106 B 106 B -
EV / Sales 2021 14,0x
EV / Sales 2022 12,8x
Nbr of Employees 11 300
Free-Float 94,1%
More Financials
Company
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within... 
Sector
Pharmaceuticals
Calendar
02/17Earnings Release
More about the company
Ratings of Zoetis Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about ZOETIS INC.
12/02Zoetis Named One of Newsweek's Most Responsible Companies for 2022
BU
11/29INSIDER SELL : Zoetis
MT
11/18ZOETIS : Top Company for Executive Women
PU
11/18Morgan Stanley Starts Zoetis at Overweight With $264 Price Target
MT
11/18Drug, feed ingredient shortages hit U.S. livestock producers
RE
11/15INSIDER SELL : Zoetis
MT
11/11INSIDER SELL : Zoetis
MT
11/05Barclays Adjusts Price Target on Zoetis to $240 From $235, Maintains Overweight Rating
MT
11/04ZOETIS INC. Management's Discussion and Analysis of Financial Condition and Results of..
AQ
11/04Tranche Update on Zoetis Inc.'s Equity Buyback Plan announced on December 12, 2018.
CI
11/04Zoetis Third-Quarter Results Top Views as Favorable Market Trends Help Lift Full-Year G..
MT
11/04Health Care Stocks Decline Premarket Thursday
MT
11/04Correction to Zoetis Earnings Article on Aug. 5
DJ
11/04Zoetis Posts Higher Q3 Adjusted EPS, Revenue, Raises 2021 Guidance
MT
11/04Zoetis Q3 Adjusted Earnings, Revenue Grow; 2021 Guidance Raised
MT
More news
News in other languages on ZOETIS INC.
11/18La escasez de medicamentos e ingredientes para piensos daña a los ganaderos de EEUU
11/11VENTE PAR DES INITIÉS : Zoetis
11/04Les résultats du troisième trimestre de Zoetis dépassent les prévisions et les tendance..
11/04Les actions du secteur de la santé en baisse jeudi avant le marché
11/04Zoetis affiche une hausse de son BPA ajusté et de son chiffre d'affaires au troisième t..
More news
Analyst Recommendations on ZOETIS INC.
More recommendations
Chart ZOETIS INC.
Duration : Period :
Zoetis Inc. Technical Analysis Chart | ZTS | US98978V1035 | MarketScreener
Technical analysis trends ZOETIS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 223,33 $
Average target price 235,00 $
Spread / Average Target 5,23%
EPS Revisions
Managers and Directors
Kristin C. Peck Chief Executive Officer & Director
Wetteny Joseph CFO, EVP & Head-Business Development
Michael B. McCallister Non-Executive Chairman
Catherine Ann Knupp Executive VP, President-Research & Development
Wafaa Mamilli Chief Information & Digital Officer
Sector and Competitors
1st jan.Capi. (M$)
ZOETIS INC.34.86%105 663
ELANCO ANIMAL HEALTH INCORPORATED-8.25%13 327
DECHRA PHARMACEUTICALS PLC41.97%7 017
VIRBAC71.43%3 889
JINYU BIO-TECHNOLOGY CO., LTD.-25.32%2 736
WUHAN KEQIAN BIOLOGY CO.,LTD-35.12%1 969